INFLUENCE OF VITAMIN-D3 ON INTESTINAL CALCIUM-ABSORPTION AND ON MINERAL METABOLISM IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEMODIALYSIS

被引:0
作者
FUNFSTUCK, R [1 ]
STEIN, G [1 ]
ABENDROTH, K [1 ]
TIETZ, U [1 ]
KOKOT, F [1 ]
BAGHDADI, F [1 ]
MULLER, A [1 ]
GUNTHER, K [1 ]
机构
[1] UNIV JENA,INNERE MED KLIN,NEPHROL ABT,O-6900 JENA,GERMANY
关键词
CHRONIC RENAL FAILURE; CA ABSORPTION; INFLUENCE OF VITAMIN-D2 AND VITAMIN-D3;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Impairment of intestinal calcium-absorption (Ca) can be observed already in early stage of renal failure. An investigation of 68 healthy control-persons and of patients with glomerulonephritis and pyelonephritis showed a deterioration of Ca-absorption with increasing renal insufficiency. These alterations are due to impairment of vitamin D3-metabolism. The lack of active metabolites of vitamin D, especially 1,25 (OH)2D3, leads to a decreased synthesis of Ca-binding proteine, calmodulin and other different systems of enzymes in the mucosal cells. These are factors which are considered to be relevant for Ca-absorption. Although these reactions according to receptor specificity are dependent of 1,25(OH)2D3-level, they can also be influenced by vitamin D2 and vitamin D3. In 29 patients, - 16 with chronic renal failure and 13 undergoing hemodialysis - 47 Ca-absorption-rate was markedly improved by daily application of 40000 IU vitamin D2 or vitamin D3 over 4 weeks: vitamin D2-group: fR (absorption-rate): 6.8 --> 16.9. - vitamin D3-group: fR (absorption-rate): 23.9 --> 27.4. Increment of the vitamin D-dosage to 80000 IU per day yielded no further benefit. Parallel to the improved intestinal Ca-absorption serum-Ca tot and serum-Ca ion normalized. The impairment of Ca-metabolismus could be better influenced by vitamin D3 than vitamin D2. In 9 patients with chronic renal failure the parameters of mineral-metabolism were normalized (serum Ca ion: 0.98 +/- 0.01 - 1.10 +/- 0.03 under longterm application of 20000 IU vitamin D3 per day over 6 months. In 11 hemodialysis patients-despite of increase of serum-Ca (Ca ion.: 1.02 +/- 0.01 --> 1.17 + 0.03 mmol/l) and increase of serum 25-(OH)D3 (28.9 + 18.2 --> 147.2 + 124.7-mu-g/ml) the hyperparathyroidism was not suppressed effectively: Enhanced PTH, alkaline phosphatase and hydroxyproline-excretion could not be corrected. As a consequence of knowledge about the impaired intestinal Ca-absorption in chronic renal failure the necessity of vitamin D-therapy is given. It should be started in an early stage of renal failure; once the stage of dialysis is reached, there is no effective control of the complex disorder of regulation by these vitamin D-agents any more.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 44 条
  • [41] Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis
    Binnur Bagci
    Gokhan Bagci
    Can Huzmeli
    Ilhan Sezgin
    Ozturk Ozdemir
    International Urology and Nephrology, 2016, 48 : 1163 - 1170
  • [42] Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis
    Bagci, Binnur
    Bagci, Gokhan
    Huzmeli, Can
    Sezgin, Ilhan
    Ozdemir, Ozturk
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (07) : 1163 - 1170
  • [43] Influence of L-carnitine on left ventricular mass, it's systolic and diastolic function, circadian blood pressure profile and heart rate variability in chronic renal failure patients undergoing hemodialysis therapy
    Wanic-Kossowska, Maria
    Tykarski, Andrzej
    Plotast, Jerzy
    Kobelski, Mikolaj
    Czekalski, Stanislaw
    ARTERIAL HYPERTENSION, 2005, 9 (02): : 103 - 111
  • [44] Effect of long-term hemodialysis on plasma lecithin:: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure:: a 9-year longitudinal study
    Mekki, K
    Bouchenak, M
    Remaoun, M
    Belleville, J
    MEDICAL SCIENCE MONITOR, 2004, 10 (08): : CR439 - CR446